Google Google

Sunday, October 5, 2008

Combining Alzheimer's drugs helps slow rate of decline in Alzheimer's Patients


Read the full text of this article at the Alzheimer's Reading Room

"My mother is currently moving into the medium stage of Alzheimer's so for us this is exciting news. I intend to send this information to our personal care physician and discuss it with him immediately.

I just finished reading a study published in the journal Alzheimer Disease and Associated Disorders that indicates combining two different kinds of Alzheimer's drugs works better one. This unique research took place over a long time frame, 1990-2005. Typical clinical trials last about 6-9 months.

Those in earlier stages of Alzheimer's disease are typically treated with cholinesterase inhibitors like Aricept, Razadyne, or Exelon. Those suffering from later stage Alzheimer's disease are usually treated with Namenda (Memantine). The study found that people who took the combination of a cholinesterase inhibitor and Memantine showed a significantly slower rate of cognitve decline than those who took only a cholinesterase inhibitor or no drug."